Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Edward Kirby, M.D.

Title
Institution
Department
Address
Phone

Mentoring
Available: 12/01/22, Expires: 07/31/27

Antibiotic resistance is a major impediment to successful treatment of patients. Multidrug efflux pumps contribute to broad-spectrum antimicrobial resistance. This mechanism of resistance is particular important in certain pathogen groups like Pseudomonas, Acinetobacter, Burkholderia and Stenotrophomonas, sometimes leaving few if any treatment options. The goal of this student project is to understand how these efflux pumps function. Based on structural understanding of efflux pumps and cross comparisons among efflux pumps and the known efflux substrates, we will generate hypothesis about mechanisms of specific substrate recognition, and test these hypothesis by directed mutation of the pump amino acid sequence, and then measuring efflux of antibiotics of interest. This is a great project for a several month to a one year commitment as the questions are well defined and will allow the student to generate their own hypotheses and test them. Techniques would include highly efficient directed mutagenesis, structural predictions based on programs such as Pymol, Maestro, and alphafold2 to drive hypothesis generation and interpret results, and minimal inhibitory concentration analysis. We collaborate extensively with Ed Yu (Case Western Reserve University School of Medcine) who solved the first structure of a bacterial efflux pump, and is a leader in the structural biology of RND efflux pumps of interest. In collaboration with Dr. Yu, we also may also express and isolate the efflux pump proteins, and Dr. Yu's laboratory will solve the structures of the pumps by cryo-EM allowing us to confirm predicted hypotheses related to structure function correlations. Our long-term goal in underestanding, structure function correlations of efflux pumps is for future design of therapeutics that can inactivate pumps and thereby restore activity of existing antibiotics. Conversely, with a better understanding of pump substrate binding we can apply this knowledge to development of antibiotics that are no longer pump substrates and can then function in pump activated organisms. We are actively interested in design of such antibiotics. I have had other Harvard Medicla Students in the laboratory, and would welcome involvement of medical students. More information about he laboratory can be found at https://www.kirbylab.org


Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI157208 (KIRBY, JAMES E ;MANETSCH, ROMAN ;YU, EDWARD W) Sep 23, 2020 - Aug 31, 2025
    NIH
    Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
    Role: Principal Investigator
  2. R01AI154860 (KIRBY, JAMES E ;O'DOHERTY, GEORGE A;YU, EDWARD W) Aug 20, 2020 - Jul 31, 2024
    NIH
    De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
    Role: Principal Investigator
  3. R21AI146485 (KIRBY, JAMES E) May 15, 2019 - Apr 30, 2021
    NIH
    Fusidic acid derivatization to enhance entry into Gram-negative pathogens
    Role: Principal Investigator
  4. R21AI140212 (MANETSCH, ROMAN) Mar 1, 2019 - Feb 28, 2021
    NIH
    Development of Streptothricin Class Antimicrobials as Novel Therapeutics
    Role: Co-Principal Investigator
  5. R03AI144196 (KIRBY, JAMES E) Feb 8, 2019 - Jan 31, 2021
    NIH
    Targeted modification of the apramycin 2-deoxystreptamine ring to block aminoglycoside modifying enzyme-based inactivation and enhance potency against multidrug-resistant Gram-negative pathogens
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kirby's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (412)
Explore
_
Co-Authors (50)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.